APA

Venere M., Hamerlik P., Wu Q., Rasmussen R. D., Song L. A., Vasanji A., Tenley N., Flavahan W. A., Hjelmeland A. B., Bartek J. & Rich J. N. (20150115). Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. : Cell death and differentiation.

Chicago

Venere M, Hamerlik P, Wu Q, Rasmussen R D, Song L A, Vasanji A, Tenley N, Flavahan W A, Hjelmeland A B, Bartek J and Rich J N. 20150115. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. : Cell death and differentiation.

Harvard

Venere M., Hamerlik P., Wu Q., Rasmussen R. D., Song L. A., Vasanji A., Tenley N., Flavahan W. A., Hjelmeland A. B., Bartek J. and Rich J. N. (20150115). Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. : Cell death and differentiation.

MLA

Venere M, Hamerlik P, Wu Q, Rasmussen R D, Song L A, Vasanji A, Tenley N, Flavahan W A, Hjelmeland A B, Bartek J and Rich J N. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. : Cell death and differentiation. 20150115.